Sidebar Ads

Thursday, February 28, 2019

Bristol-Myers shares up after top investor resists Celgene deal

Bristol-Myers Squibb Co expressed disappointment on Thursday with the opposition of its top shareholder to a $74 billion takeover of Celgene Corp, and said it would press on with what would be the largest pharmaceutical acquisition of all time.


from Reuters: Business News https://ift.tt/2StqwBb

0 comments:

Post a Comment

Why some pubs are 'getting it tight' on rates and what it could mean for your pint

Hotels have overall had an 84% rates increase, while pubs have risen by 47% due to an increase in their property valuations.. from BBC New...